SBI Securities
BIO icon

SBI Securities’s Bio-Rad Laboratories Class A BIO Stock Holding History

SBI Securities’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Hold
35
– – ﹤0.01% 1824
2026
Q1 		$9.76K Sell
35
-2
-5% -$576 ﹤0.01% 1726
2025
Q4 		$11.2K Sell
37
-2
-5% -$624 ﹤0.01% 1683
2025
Q3 		$10.9K Buy
39
+12
+44% +$3.27K ﹤0.01% 1735
2025
Q2 		$6.52K Hold
27
– – ﹤0.01% 1869
2025
Q1 		$6.58K Buy
27
+7
+35% +$2.11K ﹤0.01% 1784
2024
Q4 		$6.57K Buy
+20
New +$6.79K ﹤0.01% 1817

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SBI Securities's BIO Position: Q2 2026 in Review

SBI Securities held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 35 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1824.

SBI Securities first reported a position in BIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.2K in Q4 2025. 401 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • SBI Securities held 35 shares of Bio-Rad Laboratories Class A worth $10.3K as of Q2 2026.
  • SBI Securities left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1824 holding.
  • SBI Securities first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Bio-Rad Laboratories Class A position peaked at $11.2K in Q4 2025.
  • 401 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.